JENNIFER SCRANTON: Open Payments
NPI 1477129286 · ELKHORN, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$653 in 27 payments from 9 companies in 2025. Trend: 2023 $203 · 2024 $979 · 2025 $653
Food & beverage: $554Education: $99
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 8 | $250 |
| MAYNE PHARMA COMMERCIAL LLC | 8 | $170 |
| ABBVIE INC. | 2 | $49 |
| Exeltis, USA Inc. | 2 | $43 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $36 |
| Biogen, Inc. | 2 | $32 |
| CooperSurgical, Inc. | 1 | $30 |
| Pacira Pharmaceuticals Incorporated | 1 | $23 |
| Sumitomo Pharma America, Inc. | 1 | $18 |
Products named: Veozah, SLYND, Mirena, ZURZUVAE, Paragard T 380A, LO LOESTRIN FE, Exparel, LILETTA.
Industry payments across NE — which companies pay providers there.
